As we know that the distribution of molecular subtypes is different in young and older BC patients, with more frequent Luminal B, HER2 and triple-negative (and basal-like) subtypes in the young, we next explored the age-related, subtype-dependent BC biology through PPI networks. This evidence concerns the gene ERBB2 and breast cancer.